Amyris, Inc. (NASDAQ:AMRS – Get Rating) saw a large increase in short interest in the month of February. As of February 28th, there was short interest totalling 51,680,000 shares, an increase of 6.9% from the February 13th total of 48,350,000 shares. Currently, 21.0% of the shares of the company are sold short. Based on an average daily volume of 5,870,000 shares, the days-to-cover ratio is presently 8.8 days.
Institutional Investors Weigh In On Amyris
Several hedge funds have recently added to or reduced their stakes in the business. BlackRock Inc. boosted its holdings in Amyris by 2.7% in the first quarter. BlackRock Inc. now owns 21,667,736 shares of the biotechnology company’s stock valued at $94,470,000 after purchasing an additional 575,957 shares during the last quarter. Vanguard Group Inc. raised its position in shares of Amyris by 3.7% during the 3rd quarter. Vanguard Group Inc. now owns 19,793,472 shares of the biotechnology company’s stock worth $57,797,000 after purchasing an additional 712,965 shares during the last quarter. State of Michigan Retirement System raised its position in shares of Amyris by 6.3% during the 4th quarter. State of Michigan Retirement System now owns 7,645,000 shares of the biotechnology company’s stock worth $11,697,000 after purchasing an additional 450,000 shares during the last quarter. Edmond DE Rothschild Holding S.A. raised its position in shares of Amyris by 4.7% during the 3rd quarter. Edmond DE Rothschild Holding S.A. now owns 7,293,700 shares of the biotechnology company’s stock worth $21,298,000 after purchasing an additional 328,000 shares during the last quarter. Finally, State Street Corp raised its holdings in Amyris by 6.9% in the 3rd quarter. State Street Corp now owns 4,383,740 shares of the biotechnology company’s stock valued at $12,801,000 after acquiring an additional 283,546 shares during the last quarter. 43.08% of the stock is owned by hedge funds and other institutional investors.
Amyris Trading Down 3.8 %
Shares of AMRS stock opened at $1.27 on Friday. The company has a market cap of $419.30 million, a PE ratio of -0.72 and a beta of 1.10. Amyris has a 12-month low of $0.99 and a 12-month high of $5.15. The business’s fifty day simple moving average is $1.45 and its 200-day simple moving average is $2.10.
Wall Street Analysts Forecast Growth
Amyris Company Profile
Amyris, Inc engages in the provision of bioscience solutions. It offers its products to the health and wellness, clean beauty, and flavor and fragrance markets. The company was founded by Jack D. Newman, Kinkead Keith Reiling, and Neil Renninger on July 17, 2003 and is headquartered in Emeryville, CA.
- Get a free copy of the StockNews.com research report on Amyris (AMRS)
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
- Europe Raises Interest Rates, Should the Fed Follow?
Receive News & Ratings for Amyris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amyris and related companies with MarketBeat.com's FREE daily email newsletter.